News

Biosimilars: Forging a New Path to Accessibility Amid the Reshaping of the Global Biologics Industry

Connect with HiRO at the 2026 AAD Annual Meeting

Heading to the 2026 AAD Annual Meeting? Connect with the HiRO Team in Denver The…

Meet HiRO at PHUSE US Connect 2026 in Austin

We’re excited to join PHUSE US Connect 2026, taking place March 22–26, 2026 in Austin,…

Base to Base Biotech podcast with Sean A. MacDonald, CEO at Kainova Therapeutics – GPCRs and beating neurodegenerative diseases

Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors